Latest News in the Life Sciences Industry
GlobeNewswire
Syneos Health Expands Strategic AI Partnerships to Advance Commercial Precision Performance
14 May 2026
GlobeNewswire
IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization
13 May 2026
GlobeNewswire
Wegovy® pill delivered 21.6% weight loss in early responders and doubled mobility improvement, according to new Novo Nordisk data at ECO2026
13 May 2026
GlobeNewswire
Pharvaris Reports First Quarter 2026 Financial Results and Provides Business Update
12 May 2026
GlobeNewswire
Novo Nordisk A/S: Wegovy® delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new Novo Nordisk data at the European Congress on Obesity
12 May 2026
GlobeNewswire
Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases
12 May 2026
GlobeNewswire
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
12 May 2026
GlobeNewswire
RECORDATI: STRONG MOMENTUM OF THE GROUP CONTINUES INTO THE FIRST QUARTER OF 2026 NET REVENUE +4.9%, EBITDA(1) +5.0%, ADJUSTED NET INCOME(2) +7.2%
12 May 2026
PR Newswire Association LLC.
TrilliumBiO and Oncobit Launch Advanced Uveal Melanoma Monitoring Solution in the U.S.
12 May 2026
GlobeNewswire
Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity
12 May 2026
PR Newswire Association LLC.
ACROBiosystems Innovation Day Lands in Zurich: Top Minds Unite to Explore Biotech Frontiers
12 May 2026
GlobeNewswire
Q1 2026 Update: Tecan on track with low-single-digit local currency growth in Q1; full-year 2026 outlook confirmed
12 May 2026
GlobeNewswire
Roche receives CE mark for new blood test to detect Alzheimer's pathology: Elecsys® plasma phosphorylated-tau 217 (pTau217)
12 May 2026
GlobeNewswire
Pharvaris Announces Closing of $132.3 Million Underwritten Offering of Ordinary Shares and Full Exercise of Underwriters’ Option to Purchase Additional Shares
11 May 2026
Upcoming Events All Events
- October 2026
- Milan: CPHI Milan 2026
- Basel: 26th Annual Biotech in Europe Forum
- Yokohama: BioJapan